We are live on ! Find out more
MSFP

Mark Sheptoff Financial Planning Portfolio holdings

AUM $189M
1-Year Est. Return 28.82%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+28.82%
3 Year Est. Return
+85.85%
5 Year Est. Return
+121.15%
10 Year Est. Return
+416.47%
AUM
$186M
AUM Growth
-$1.81M
Cap. Flow
+$1.73M
Cap. Flow %
0.93%
Top 10 Hldgs %
50.23%
Holding
453
New
25
Increased
53
Reduced
54
Closed
22

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$1.01M
2
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$923K
3
CLS icon
Celestica
CLS
+$664K
4
NVDA icon
NVIDIA
NVDA
+$551K
5
INTC icon
Intel
INTC
+$372K

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$1.13M
2
NFLX icon
Netflix
NFLX
+$254K
3
HRL icon
Hormel Foods
HRL
+$251K
4
LMT icon
Lockheed Martin
LMT
+$246K
5
CVS icon
CVS Health
CVS
+$166K

Sector Composition

Rank Sector Weight
1 Technology 26.88%
2 Healthcare 22.96%
3 Consumer Staples 11.13%
4 Utilities 9.6%
5 Industrials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBA
401
DELISTED
Walgreens Boots Alliance
WBA
$1.76K ﹤0.01%
100
TJX icon
402
TJX Companies
TJX
$178B
$1.57K ﹤0.01%
13
FNDA icon
403
Schwab Fundamental US Small Company Index ETF
FNDA
$9.38B
$1.54K ﹤0.01%
52
-52
-50% -$1.59K
NVO
404
Novo Nordisk
NVO
$209B
$1.1K ﹤0.01%
13
PLUG icon
405
Plug Power
PLUG
$3.04B
$1.09K ﹤0.01%
510
WBD icon
406
Warner Bros
WBD
$67.1B
$1.06K ﹤0.01%
100
INTF icon
407
iShares International Equity Factor ETF
INTF
$3.72B
$1K ﹤0.01%
35
DBVT
408
DBV Technologies
DBVT
$847M
$927 ﹤0.01%
300
+240
+400% +$818
GEM icon
409
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.72B
$926 ﹤0.01%
29
BHF icon
410
Brighthouse Financial
BHF
$3.5B
$865 ﹤0.01%
18
GEHC icon
411
GE HealthCare
GEHC
$32.4B
$704 ﹤0.01%
9
ALIT icon
412
Alight
ALIT
$407M
$692 ﹤0.01%
5
EDR
413
DELISTED
Endeavor Group Holdings, Inc.
EDR
$626 ﹤0.01%
20
ALEC icon
414
Alector
ALEC
$199M
$567 ﹤0.01%
300
HPE icon
415
Hewlett Packard
HPE
$70.5B
$534 ﹤0.01%
25
IPSC icon
416
Century Therapeutics
IPSC
$361M
$505 ﹤0.01%
500
NKTX icon
417
Nkarta
NKTX
$172M
$498 ﹤0.01%
200
FATE icon
418
Fate Therapeutics
FATE
$326M
$495 ﹤0.01%
300
MRNA icon
419
Moderna
MRNA
$23.6B
$416 ﹤0.01%
10
-200
-95% -$9.56K
DNOW icon
420
DNOW Inc
DNOW
$2.99B
$325 ﹤0.01%
25
NKE icon
421
Nike
NKE
$61.9B
$303 ﹤0.01%
4
-250
-98% -$19.6K
LCID icon
422
Lucid Motors
LCID
$2.77B
$302 ﹤0.01%
10
FE icon
423
FirstEnergy
FE
$27.5B
$300 ﹤0.01%
8
+1
+14% +$42
ASIX icon
424
AdvanSix
ASIX
$444M
$285 ﹤0.01%
10
EVH icon
425
Evolent Health
EVH
$447M
$281 ﹤0.01%
25

Similar funds

Mark Sheptoff Financial Planning's Q4 2024 Portfolio in Review

As of Q4 2024, Mark Sheptoff Financial Planning held 453 positions worth $186M, down 0.96% from $188M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Mark Sheptoff Financial Planning's Q4 2024 filing shows 25 new, 53 increased, 54 reduced and 22 closed positions. Its largest new stake was Neuberger Energy Infrastructure and Income Fund Inc: 16,300 shares worth $144K. The largest sale was UnitedHealth, an estimated $1.13M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Mark Sheptoff Financial Planning's largest Q4 2024 buy was Neuberger Energy Infrastructure and Income Fund Inc: 16,300 shares worth $144K.
  • Mark Sheptoff Financial Planning added most to RTX Corp in Q4 2024, an estimated $1.01M increase.
  • Mark Sheptoff Financial Planning's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $1.13M.
  • Mark Sheptoff Financial Planning fully exited Pan American Silver in Q4 2024, selling an estimated $70.1K.
  • Mark Sheptoff Financial Planning's ten largest holdings make up 50% of its $186M portfolio in Q4 2024.
  • Mark Sheptoff Financial Planning opened 25 new positions and closed 22 in Q4 2024.
  • Mark Sheptoff Financial Planning's portfolio value fell 0.96% quarter-over-quarter to $186M.

Based on Mark Sheptoff Financial Planning's 13F filing for Q4 2024, filed 12 Feb 2025.